Artivion Inc (AORT) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.41 is considered Overvalued compared with the five-year average of 102.78. The fair price of Artivion Inc (AORT) is between 25.30 to 36.71 according to relative valuation method. Compared to the current price of 38.55 USD , Artivion Inc By Overvalued By 5.02%.

Relative Value

Fair Zone

25.30-36.71

Current Price：38.55

5.02%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Artivion Inc (AORT) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Artivion Inc (AORT) has a current Price-to-Book (P/B) ratio of 4.80. Compared to its 3-year average P/B ratio of 3.35, the current P/B ratio is approximately 43.24% higher. Relative to its 5-year average P/B ratio of 3.08, the current P/B ratio is about 55.85% higher. Artivion Inc (AORT) has a Forward Free Cash Flow (FCF) yield of approximately 0.83%. Compared to its 3-year average FCF yield of 0.18%, the current FCF yield is approximately 372.13% lower. Relative to its 5-year average FCF yield of -0.53%, the current FCF yield is about -257.27% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AORT competitors is 6.53, providing a benchmark for relative valuation. Artivion Inc Corp (AORT.N) exhibits a P/S ratio of 4.41, which is -32.49% above the industry average. Given its robust revenue growth of 19.20%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AORT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AORT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AORT currently overvalued or undervalued?

What is Artivion Inc (AORT) fair value?

AORT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Artivion Inc (AORT) is between 25.30 to 36.71 according to relative valuation method.

How does AORT's valuation metrics compare to the industry average?

The average P/S ratio for AORT's competitors is 6.53, providing a benchmark for relative valuation. Artivion Inc Corp (AORT) exhibits a P/S ratio of 4.41, which is -32.49% above the industry average. Given its robust revenue growth of 19.20%, this premium appears unsustainable.

What is the current P/B ratio for Artivion Inc (AORT) as of Mar 03 2026?

As of Mar 03 2026, Artivion Inc (AORT) has a P/B ratio of 4.80. This indicates that the market values AORT at 4.80 times its book value.

What is the current FCF Yield for Artivion Inc (AORT) as of Mar 03 2026?

As of Mar 03 2026, Artivion Inc (AORT) has a FCF Yield of 0.83%. This means that for every dollar of Artivion Inc's market capitalization, the company generates 0.83 cents in free cash flow.

What is the current Forward P/E ratio for Artivion Inc (AORT) as of Mar 03 2026?

As of Mar 03 2026, Artivion Inc (AORT) has a Forward P/E ratio of 124.19. This means the market is willing to pay $124.19 for every dollar of Artivion Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Artivion Inc (AORT) as of Mar 03 2026?

As of Mar 03 2026, Artivion Inc (AORT) has a Forward P/S ratio of 4.41. This means the market is valuing AORT at $4.41 for every dollar of expected revenue over the next 12 months.

AORT Valuation